Outcome of patients with HTLV-1-associated adult T-cell leukemia/lymphoma after SCT: a retrospective study by the EBMT LWP
Ali Bazarbachi(American University of Beirut), Olivier Hermine(Centre National de la Recherche Scientifique), Kate Cwynarski(Royal London Hospital), Mohamad Mohty(Sorbonne Université), Hervé Finel, Anna Sureda(Institut d'Investigació Biomédica de Bellvitge), Peter Dreger(Heidelberg University), Paul Fields(St Thomas' Hospital), Kavita Raj(Johns Hopkins Hospital), A. Nagler, Ariane Boumendil(Inserm)
Cited by 84
Related Papers
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
|New England Journal of Medicine|2021|1.6k
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease
|New England Journal of Medicine|2020|859
Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia
|JAMA Internal Medicine|2020|777